BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10539878)

  • 1. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.
    Vichinsky EP; Neumayr LD; Haberkern C; Earles AN; Eckman J; Koshy M; Black DM
    Am J Hematol; 1999 Nov; 62(3):129-38. PubMed ID: 10539878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: retrospective study].
    Ould amar AK; Delattre O; Godbille C; Béra O; Halbout PA; Catonné Y
    Transfus Clin Biol; 2003 Apr; 10(2):61-6. PubMed ID: 12763144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
    Vichinsky EP; Haberkern CM; Neumayr L; Earles AN; Black D; Koshy M; Pegelow C; Abboud M; Ohene-Frempong K; Iyer RV
    N Engl J Med; 1995 Jul; 333(4):206-13. PubMed ID: 7791837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique.
    Ould Amar K; Rouvillain JL; Loko G
    Transfus Clin Biol; 2013 Mar; 20(1):30-4. PubMed ID: 23522689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group.
    Waldron P; Pegelow C; Neumayr L; Haberkern C; Earles A; Wesman R; Vichinsky E
    J Pediatr Hematol Oncol; 1999; 21(2):129-35. PubMed ID: 10206459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery.
    Al-Samak ZM; Al-Falaki MM; Pasha AA
    Middle East J Anaesthesiol; 2008 Jun; 19(5):983-95. PubMed ID: 18637600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple drilling compared with standard core decompression for avascular necrosis of the femoral head in sickle cell disease patients.
    Al Omran A
    Arch Orthop Trauma Surg; 2013 May; 133(5):609-13. PubMed ID: 23494112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative complications in patients with sickle cell disease. An orthopedic perspective.
    Garden MS; Grant RE; Jebraili S
    Am J Orthop (Belle Mead NJ); 1996 May; 25(5):353-6. PubMed ID: 8727085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative care for patients with sickle cell who are undergoing total hip replacement as treatment for osteonecrosis.
    Hammer M; Geier KA; Aksoy S; Reynolds HM
    Orthop Nurs; 2003; 22(6):384-97. PubMed ID: 14705468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the hip in sickle cell hemoglobinopathy.
    Moran MC
    Am J Orthop (Belle Mead NJ); 1995 Jan; 24(1):18-24. PubMed ID: 7773653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total hip replacement in sickle cell disorder: A preliminary report of challenges and early outcome of 21 consecutive patients.
    Katchy AU; Anyaehie UE; Nwadinigwe CU; Eyichukwu GO
    Niger J Clin Pract; 2018 Apr; 21(4):492-495. PubMed ID: 29607863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncemented Total Hip Arthroplasty in Sickle-Cell Disease: Long-Term Results.
    Ilyas I; Alrumaih HA; Rabbani S
    J Arthroplasty; 2018 Feb; 33(2):477-481. PubMed ID: 28993082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative blood transfusions for sickle cell disease.
    Hirst C; Williamson L
    Cochrane Database Syst Rev; 2012 Jan; 1():CD003149. PubMed ID: 22258951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total hip arthroplasty after avascular necrosis due to sickle cell disease in Senegal: series of 48 replacements].
    Sene M; Dansoko A; Ndiaye A; Mbaye E; Niang CD; Faye M
    Med Trop (Mars); 2009 Dec; 69(6):573-6. PubMed ID: 20099672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study.
    Mukisi-Mukaza M; Manicom O; Alexis C; Bashoun K; Donkerwolcke M; Burny F
    Orthop Traumatol Surg Res; 2009 Nov; 95(7):498-504. PubMed ID: 19801210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar hip replacement in sickle cell disease.
    Sanjay BK; Moreau PG
    Int Orthop; 1996; 20(4):222-6. PubMed ID: 8872544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Sickle Cell Patients After Cementless Total Hip Arthroplasty.
    Azam MQ; Sadat-Ali M
    J Arthroplasty; 2016 Nov; 31(11):2536-2541. PubMed ID: 27240962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous bilateral total hip arthroplasty in sickle cell disease.
    Ilyas I; Moreau P
    J Arthroplasty; 2002 Jun; 17(4):441-5. PubMed ID: 12066273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total hip arthroplasty in sickle cell hemoglobinopathy.
    Moran MC; Huo MH; Garvin KL; Pellicci PM; Salvati EA
    Clin Orthop Relat Res; 1993 Sep; (294):140-8. PubMed ID: 8358906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy.
    Wali YA; al Okbi H; al Abri R
    Pediatr Hematol Oncol; 2003; 20(1):7-13. PubMed ID: 12687748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.